Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| 1 |
Linde
LIN
|
+$397M |
| 2 |
NVIDIA
NVDA
|
+$373M |
| 3 |
AT&T
T
|
+$295M |
| 4 |
Energy Select Sector SPDR Fund
XLE
|
+$274M |
| 5 |
Walmart
WMT
|
+$273M |
Top Sells
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.19B |
| 2 |
Lam Research
LRCX
|
+$379M |
| 3 |
Apple
AAPL
|
+$367M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$320M |
| 5 |
Boeing
BA
|
+$299M |
Sector Composition
| 1 | Technology | 16.96% |
| 2 | Healthcare | 16.1% |
| 3 | Financials | 12.4% |
| 4 | Consumer Discretionary | 11.37% |
| 5 | Industrials | 11.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
4026
Applied Optoelectronics
AAOI
$1.84B
| $84K | ﹤0.01% |
37,981
-9,517
| -20% | -$21K |
|
4027
VYNE Therapeutics
VYNE
$7.8M
| $84K | ﹤0.01% |
27,312
+200
| +0.7% | +$615 |
|
|
DMTK
4028
DELISTED
DermTech, Inc. Common Stock
DMTK
| $84K | ﹤0.01% |
22,926
-67,509
| -75% | -$247K |
|
4029
Arqit Quantum
ARQQ
$505M
| $83K | ﹤0.01% |
2,359
+1,812
| +331% | +$63.8K |
|
|
SBLX
4030
StableX Technologies, Inc. Common Stock
SBLX
$3.73M
| $83K | ﹤0.01% |
1,176
-533
| -31% | -$37.6K |
|
4031
System1
SST
$71.3M
| $83K | ﹤0.01% |
1,939
-6,795
| -78% | -$291K |
|
4032
Ericsson
ERIC
$26.5B
| $82K | ﹤0.01% |
13,935
-6,728,168
| -100% | -$39.6M |
|
4033
HF Foods Group
HFFG
$183M
| $82K | ﹤0.01% |
+20,884
| New | +$82K |
|
4034
PAVmed
PAVM
$8.78M
| $82K | ﹤0.01% |
14,686
-7,038
| -32% | -$39.3K |
|
4035
Protara Therapeutics
TARA
$122M
| $82K | ﹤0.01% |
26,321
-3,305
| -11% | -$10.3K |
|
4036
Granite Ridge Resources
GRNT
$702M
| $81K | ﹤0.01% |
13,760
-2,321
| -14% | -$13.7K |
|
4037
P3 Health Partners
PIII
$28.2M
| $81K | ﹤0.01% |
1,524
-134
| -8% | -$7.12K |
|
4038
Exagen
XGN
$205M
| $81K | ﹤0.01% |
33,155
-3,432
| -9% | -$8.39K |
|
|
PET
4039
DELISTED
Wag!
PET
| $80K | ﹤0.01% |
+35,891
| New | +$80K |
|
4040
Rockwell Medical
RMTI
$57.2M
| $80K | ﹤0.01% |
44,360
-8,684
| -16% | -$15.7K |
|
|
TLIS
4041
DELISTED
Talis Biomedical Corporation Common Stock
TLIS
| $80K | ﹤0.01% |
10,911
+3,509
| +47% | +$25.7K |
|
4042
GT Biopharma
GTBP
$2.85M
| $79K | ﹤0.01% |
4,764
+367
| +8% | +$6.09K |
|
4043
KNOT Offshore Partners
KNOP
$313M
| $79K | ﹤0.01% |
14,791
-207,705
| -93% | -$1.11M |
|
4044
Spruce Power Holding Corp
SPRU
$30.3M
| $79K | ﹤0.01% |
12,024
-16,305
| -58% | -$107K |
|
4045
Advent Technologies
ADN
$7.72M
| $78K | ﹤0.01% |
+2,451
| New | +$78K |
|
|
MSC
4046
Studio City International Holdings
MSC
$763M
| $78K | ﹤0.01% |
11,790
-9,975
| -46% | -$66K |
|
4047
Offerpad Solutions
OPAD
$131M
| $78K | ﹤0.01% |
9,870
+639
| +7% | +$5.05K |
|
|
PVLA
4048
Palvella Therapeutics, Inc. Common Stock
PVLA
$604M
| $78K | ﹤0.01% |
998
-5,938
| -86% | -$464K |
|
4049
Rafael Holdings
RFL
$46.7M
| $77K | ﹤0.01% |
50,514
-26,933
| -35% | -$41.1K |
|
4050
Acurx Pharmaceuticals
ACXP
$6.61M
| $76K | ﹤0.01% |
1,103
-352
| -24% | -$24.3K |
|